KI vs KIO₃: Only One Is FDA-Approved

If you're shopping for potassium iodide online, you'll eventually encounter potassium iodate. Often it's cheaper. Sometimes it's marketed as "superior" or "more stable." The packaging might look nearly identical to KI products. It's easy to assume they're interchangeable.

They're not. And the authorities who actually handle radiation emergencies — the FDA, CDC, and WHO — are remarkably clear about which one you should buy.

The Chemical Difference

Let's start with what these actually are:

The molecular difference is one oxygen atom. KIO₃ has three oxygen atoms attached to the iodine; KI has none. That oxygen changes how the compound behaves in your body and how stable it is on the shelf.

Here's the critical point: because potassium iodate contains less iodine by weight, you need a larger dose to achieve the same thyroid protection. An adult needs 130mg of KI, but approximately 170mg of KIO₃ to get equivalent iodine saturation.

The FDA Position: Unambiguous

The FDA is crystal clear on this:

"Only potassium iodide should be used for thyroid blocking. Potassium iodate is not approved by the FDA for this use."

This isn't a subtle preference. It's a bright-line regulatory distinction. The FDA has gone through the full drug approval process for potassium iodide products. They have reviewed manufacturing standards, stability data, clinical efficacy, and safety profiles. They have never done this for potassium iodate as a thyroid-blocking agent.

What does this mean practically?

• KI products can legally claim they are "FDA-approved for radiation emergencies"
• KIO₃ products cannot make this claim
• KI products must follow Current Good Manufacturing Practice (cGMP) regulations
• KIO₃ products, if sold as supplements, follow different quality standards

The FDA's approval matters because it means the product has demonstrated, through documented testing, that it delivers the stated dose reliably and consistently. When you're dealing with something as serious as radiation protection, that regulatory oversight provides real assurance.

CDC and WHO: The Same Recommendation

The FDA isn't alone. The CDC's radiation emergency guidance specifically recommends potassium iodide, not iodate. Their dosing tables, their stockpile recommendations, and their public guidance all reference KI exclusively.

The World Health Organization is equally clear:

"Potassium iodide (KI) is the preferred salt for thyroid blocking. Potassium iodate (KIO₃) may be used as an alternative if KI is not available."

Read that carefully. The WHO says KIO₃ "may be used as an alternative if KI is not available." That's a backup option, not an equivalent choice. The reasons for this preference are well-documented.

Why KIO₃ Has More Side Effects

The primary issue with potassium iodate is gastrointestinal irritation. The iodate ion (IO₃⁻) is more oxidizing than the iodide ion (I⁻). When it reaches your stomach, it can cause:

• Nausea and vomiting
• Abdominal pain
• Diarrhea
• Gastric irritation

These side effects aren't theoretical. Studies of populations taking iodate for thyroid blocking have reported higher rates of gastrointestinal complaints compared to those taking iodide. During the Chernobyl response, some populations given potassium iodate experienced significant nausea, which led to non-compliance — people stopped taking the medication because it made them sick.

The higher dose required for KIO₃ compounds this issue. Remember, adults need about 170mg of KIO₃ versus 130mg of KI. That's a 30% larger pill or more tablets to swallow, increasing the chance of stomach upset.

For children, the side effect profile is even more concerning. Children's smaller body mass means the relative dose is higher, and their digestive systems may be more sensitive to irritants. The WHO specifically notes that KI is preferred for pediatric populations.

The Stability Argument: Overrated for US Households

Proponents of potassium iodate often cite stability. KIO₃ is indeed more stable than KI, particularly in hot, humid conditions. The iodate form resists degradation better when stored in tropical climates without climate control.

This is why some countries — particularly those with tropical climates and less reliable infrastructure — have chosen to stockpile potassium iodate. If you're storing KI in a warehouse in India or Brazil with no air conditioning, KIO₃'s stability advantage becomes meaningful.

But for typical US households? Not so much.

Most Americans store medications in climate-controlled environments. A drawer in your bedroom, a cabinet in your kitchen, or a box in your closet stays within reasonable temperature and humidity ranges year-round. Under these conditions, the stability difference between KI and KIO₃ is minimal.

Consider this: FDA-approved KI products like iOSAT have validated 10-year shelf lives. The tablets are individually foil-sealed, protecting them from moisture and light. If stored properly, KI remains stable for a decade — which is longer than most people keep emergency supplies anyway.

The stability advantage of KIO₃ is real, but it's solving a problem most American households don't have.

Dosing Confusion: Another Strike Against Iodate

The different iodine content creates real-world dosing confusion. We've seen KIO₃ products marketed with dosing instructions that don't match WHO or FDA equivalents. Some assume 1:1 dosing with KI. Others use odd increments that are hard to measure.

Here's the correct equivalency:

Notice the problem? KIO₃ doses don't align with standard tablet sizes. A 170mg dose might require taking multiple tablets or splitting oddly-sized pills. This complexity increases the risk of dosing errors during an already stressful emergency.

With FDA-approved KI, dosing is straightforward: one 130mg tablet for adults, one 65mg tablet for children 3-12. The tablets are scored for splitting if needed. Everything is designed for clarity under pressure.

What If You Already Have KIO₃?

If you've already purchased potassium iodate, you don't need to panic. It's not dangerous or fake. It will likely provide thyroid protection if used correctly. The WHO considers it an acceptable alternative when KI isn't available.

But we recommend replacing it with KI when you can. Here's why:

• Lower side effect risk: KI is gentler on your stomach
• Simpler dosing: Standard tablets match official guidance
• Regulatory certainty: FDA approval means quality standards
• Universal recognition: US healthcare providers are trained on KI, not iodate

If you do use KIO₃ in an emergency, follow WHO-equivalent dosing (approximately 130% of the KI dose) and be aware that gastrointestinal side effects are more likely.

What to Buy Instead

If you want proper potassium iodide, here are our top FDA-approved picks:

iOSAT 130mg — The government stockpile standard. 10-year shelf life, individually sealed, one tablet per adult dose. This is what federal agencies buy for their own stockpiles.

ThyroSafe 65mg — Better for families with kids ages 3-12. No pill splitting required for children. Adults take two tablets, kids take one. Simple.

Both carry full FDA approval for radiation emergencies. Both follow Current Good Manufacturing Practice regulations. Both have documented stability data and quality assurance. These are the products US health authorities actually recommend.

Keep Reading